Tatjana Paunesku Selected Research

Axonemal Dyneins

7/2007

Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatjana Paunesku Research Topics

Disease

26	Neoplasms (Cancer) 10/2021 - 11/2005
3	Pheochromocytoma 04/2012 - 08/2011
2	Peripheral Nervous System Diseases (PNS Diseases) 09/2020 - 07/2019
2	Carcinogenesis 01/2015 - 09/2013
2	Hypoxia (Hypoxemia) 05/2007 - 11/2005
1	Glioblastoma (Glioblastoma Multiforme) 10/2021
1	Glioma (Gliomas) 10/2021
1	Lymphoma (Lymphomas) 01/2021
1	Neuroblastoma 01/2021
1	Pain (Aches) 09/2020
1	Squamous Cell Carcinoma of Head and Neck 11/2019
1	Dehydration (Water Stress) 01/2017
1	Liver Neoplasms (Liver Cancer) 08/2016
1	Hyperthermia 01/2015
1	Inflammation (Inflammations) 01/2014
1	Wounds and Injuries (Trauma) 01/2014
1	Ovarian Neoplasms (Ovarian Cancer) 02/2012
1	Prostatic Neoplasms (Prostate Cancer) 04/2011
1	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2007
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 07/2007
1	Leiomyoma (Uterine Fibroids) 03/2007

Drug/Important Bio-Agent (IBA)

4	titanium dioxide (Titania)FDA Link 01/2018 - 04/2011
3	Pharmaceutical PreparationsIBA 10/2021 - 02/2012
3	NanoconjugatesIBA 01/2021 - 09/2008
3	Contrast MediaIBA 01/2019 - 07/2006
3	Peptides (Polypeptides)IBA 08/2016 - 05/2011
3	PlutoniumIBA 04/2012 - 08/2011
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 07/2007
2	GoldIBA 10/2021 - 01/2015
2	PlatinumIBA 09/2020 - 07/2019
2	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 01/2018
2	ferric oxide (iron oxide)IBA 08/2016 - 02/2012
2	ErbB Receptors (EGF Receptor)IBA 12/2013 - 09/2011
2	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2013 - 07/2007
2	Polyvinyl AlcoholIBA 05/2007 - 11/2005
1	Nucleic AcidsIBA 10/2021
1	SilverIBA 10/2021
1	3,4-Dihydroxyphenylacetic AcidIBA 01/2021
1	CobaltIBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	YttriumIBA 01/2021
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 11/2019
1	AlbuminsIBA 11/2019
1	ZincIBA 11/2019
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	Ethanol (Ethyl Alcohol)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 08/2016
1	CortactinIBA 08/2016
1	Biological ProductsIBA 01/2015
1	Cyclin D1IBA 01/2014
1	AB103IBA 01/2014
1	IsotopesIBA 04/2012
1	ElementsIBA 04/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2012
1	Transferrin (beta 2 Transferrin)IBA 02/2012
1	AnthracyclinesIBA 02/2012
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2012
1	LigandsIBA 09/2011
1	AntigensIBA 09/2011
1	GadoliniumIBA 11/2009
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 08/2009
1	Single-Stranded DNA (DNA, Single Stranded)IBA 06/2009
1	OligonucleotidesIBA 06/2009
1	Amifostine (Ethyol)FDA LinkGeneric 08/2008
1	SuspensionsIBA 06/2008
1	Annexin A2 (Annexin II)IBA 07/2007
1	UbiquitinIBA 07/2007
1	ProgranulinsIBA 07/2007
1	RNA (Ribonucleic Acid)IBA 07/2007
1	Axonemal DyneinsIBA 07/2007
1	Monoclonal AntibodiesIBA 05/2007
1	Transcription Factors (Transcription Factor)IBA 05/2007
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2006
1	Hematoxylin (Haematoxylon)IBA 04/2006

Therapy/Procedure

8	Therapeutics 10/2021 - 11/2005
3	Drug Therapy (Chemotherapy) 01/2021 - 07/2019
3	Catheters 08/2016 - 07/2006
2	Radiotherapy 01/2021 - 01/2015
1	Intravenous Administration 10/2021
1	Microspheres (Microsphere) 01/2021
1	Synchrotrons 01/2021
1	Uterine Artery Embolization 03/2007
1	Injections 07/2006